UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Annals of oncology, 2014-07, Vol.25 (7), p.1328-1333

2014

Volltextzugriff (PDF)

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results

European journal of cancer (1990), 2018-04, Vol.93, p.19-27

2018

Volltextzugriff (PDF)

A randomized, open label, phase II study of prophylactic octreotide (OCT) to prevent/reduce the frequency and severity of diarrhea in patients (pts) receiving lapatinib (LAP) with capecitabine (CAP) for the treatment of metastatic breast cancer (mBC)

Annals of oncology, 2018-10, Vol.29, p.viii102-viii102

2018

Volltextzugriff (PDF)

Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experience

Bone marrow transplantation (Basingstoke), 2007-09, Vol.40 (6), p.567-572

2007

Volltextzugriff (PDF)

Which Parameters of Nutritional Status Should We Choose for Nutritional Assessment During Hematopoietic Stem Cell Transplantation?

Transplantation proceedings, 2007-11, Vol.39 (9), p.2902-2904

2007

Volltextzugriff (PDF)

Antisense therapy in cancer

Cancer treatment reviews, 2000-10, Vol.26 (5), p.333-350

2000

Volltextzugriff (PDF)

Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience

Journal of B.U. ON., 2007-10, Vol.12 (4), p.477

2007

Volltextzugriff (PDF)

Prevention of Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Valganciclovir: Single Center Experience

Journal of chemotherapy (Florence), 2008-02, Vol.20 (1), p.140-142, Article 140

2008

Volltextzugriff (PDF)

P156 - 3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting

Breast (Edinburgh), 2019-03, Vol.44, p.S68-S68

2019

Volltextzugriff (PDF)

3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting

Breast (Edinburgh), 2019-03, Vol.44, p.S68

2019

Volltextzugriff (PDF)

How can we help patients with refractory chronic graft versus host disease- single centre experience

Neoplasma, 2007, Vol.54 (5), p.431

2007

Volltextzugriff (PDF)

319PA randomized, open label, phase II study of prophylactic octreotide (OCT) to prevent/reduce the frequency and severity of diarrhea in patients (pts) receiving lapatinib (LAP) with capecitabine (CAP) for the treatment of metastatic breast cancer (mBC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience

Neoplasma, 2005, Vol.52 (3), p.238

2005

Volltextzugriff (PDF)

O-027A pivotal phase 3 trial of MABp1 in advanced colorectal cancer

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii128-ii128

2016

Volltextzugriff (PDF)

O-027 A pivotal phase 3 trial of MABp1 in advanced colorectal cancer

Annals of oncology, 2016-06, Vol.27, p.ii128

2016

Volltextzugriff (PDF)

Nutritional assessment during allogeneic hematopoietic stem cell transplantation: single centre experience

Journal of B.U. ON., 2007-04, Vol.12 (2), p.253

2007

Volltextzugriff (PDF)

Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.2006-2017

2021

Volltextzugriff (PDF)

One-year safety, immunogenicity, and survival results from a phase III study comparing SB3 (a proposed trastuzumab biosimilar) and originator trastuzumab in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment

Annals of oncology, 2017-09, Vol.28, p.v45-v45

2017

Volltextzugriff (PDF)

A dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB

Annals of oncology, 2017-09, Vol.28, p.v238-v238

2017

Volltextzugriff (PDF)

Multimodality treatment of germ cell cancer patients who had progression or relapse after high dose chemotherapy and autologous bone marrow transplantation

Journal of B.U. ON., 2007-07, Vol.12 (3), p.335

2007

Volltextzugriff (PDF)

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

The New England journal of medicine, 2012-07, Vol.367 (2), p.107-114

2012

Volltextzugriff (PDF)

Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)

Annals of oncology, 2017-09, Vol.28, p.v408-v409

2017

Volltextzugriff (PDF)

Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis

Clinical gastroenterology and hepatology, 2019-06, Vol.17 (7), p.1285-1294.e1

2019

Volltextzugriff (PDF)

Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders

Gastroenterology (New York, N.Y. 1943), 2018-01, Vol.154 (1), p.65-76.e11

2018

Volltextzugriff (PDF)

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Breast cancer research and treatment, 2021-11, Vol.190 (2), p.265-275

2021

Volltextzugriff (PDF)

1 – 25 von 1.229

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.133)
Mit Volltextzugriff
(869)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.142)
Polnisch
(93)
Deutsch
(4)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

A phase III study comparing SB3 (a proposed trastuzumab biosimilar) and trastuzumab reference product in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment: Final safety, immunogenicity and survival results

A randomized, open label, phase II study of prophylactic octreotide (OCT) to prevent/reduce the frequency and severity of diarrhea in patients (pts) receiving lapatinib (LAP) with capecitabine (CAP) for the treatment of metastatic breast cancer (mBC)

Biochemical indices for the assessment of nutritional status during hematopoietic stem cell transplantation: are they worth using? A single center experience

Which Parameters of Nutritional Status Should We Choose for Nutritional Assessment During Hematopoietic Stem Cell Transplantation?

Antisense therapy in cancer

Palifermin for prevention of oral mucositis after haematopoietic stem cell transplantation- single centre experience

Prevention of Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation with Valganciclovir: Single Center Experience

P156 - 3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting

3-year follow-up of a phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in HER2 positive early or locally advanced breast cancer in neoadjuvant setting

How can we help patients with refractory chronic graft versus host disease- single centre experience

319PA randomized, open label, phase II study of prophylactic octreotide (OCT) to prevent/reduce the frequency and severity of diarrhea in patients (pts) receiving lapatinib (LAP) with capecitabine (CAP) for the treatment of metastatic breast cancer (mBC)

Allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of metastatic renal cell carcinoma -- single center experience

O-027A pivotal phase 3 trial of MABp1 in advanced colorectal cancer

O-027 A pivotal phase 3 trial of MABp1 in advanced colorectal cancer

Nutritional assessment during allogeneic hematopoietic stem cell transplantation: single centre experience

Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features

One-year safety, immunogenicity, and survival results from a phase III study comparing SB3 (a proposed trastuzumab biosimilar) and originator trastuzumab in HER2-positive early breast cancer treated with neoadjuvant-adjuvant treatment

A dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB

Multimodality treatment of germ cell cancer patients who had progression or relapse after high dose chemotherapy and autologous bone marrow transplantation

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Results of the randomized, placebo-controlled phase I/IIB trial of CV9104, an mRNA based cancer immunotherapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)

Opioid Use and Potency Are Associated With Clinical Features, Quality of Life, and Use of Resources in Patients With Gastroparesis

Aprepitant Has Mixed Effects on Nausea and Reduces Other Symptoms in Patients With Gastroparesis and Related Disorders

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)

Suchergebnisse filtern